Advertisement

The Scientist

» drug development, culture and immunology

Most Recent

image: Bacterial Enzyme an Antismoking Aid?

Bacterial Enzyme an Antismoking Aid?

By | August 10, 2015

A compound that degrades nicotine before it reaches the brain could serve as a successful smoking cessation therapy, according to an in vitro study.

0 Comments

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

image: Book Excerpt from <em>Life on the Edge</em>

Book Excerpt from Life on the Edge

By | August 1, 2015

In Chapter 4, “The quantum beat,” authors Johnjoe McFadden and Jim Al-Khalili rethink Newton’s apple from a quantum-biological perspective.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | August 1, 2015

Gods of the Morning, Hedonic Eating, A Beautiful Question, and Genomic Messages

0 Comments

image: Good Vibrations

Good Vibrations

By | August 1, 2015

Does a delicately orchestrated balance between quantum and classical physics distinguish living from nonliving things?

15 Comments

image: Rethinking Lymphatic Development

Rethinking Lymphatic Development

By | August 1, 2015

Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.

1 Comment

image: The Human Touch

The Human Touch

By | August 1, 2015

Can mice with humanlike tissues better model drug effects in people?

0 Comments

image: The Spleen Collectors

The Spleen Collectors

By | August 1, 2015

Donated organs are helping researchers map out the immune system in humans.

0 Comments

image: Yun “Nancy” Huang: Eager for Epigenetics

Yun “Nancy” Huang: Eager for Epigenetics

By | August 1, 2015

Assistant Professor, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston. Age: 35

0 Comments

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

Advertisement
Arbor Assays
Arbor Assays

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Simulating Scientific Sabotage, For Fun
  3. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
Bio-Rad
Bio-Rad
Advertisement
Life Technologies